Antibody data
- Antibody Data
- Antigen structure
- References [16]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA007053 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA007053, RRID:AB_1233803
- Product name
- Anti-CDK19
- Antibody type
- Polyclonal
- Description
- Affinity purified using the PrEST antigen as affinity ligand
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Antigen sequence
KGDKNQQQQQNQHQQPTAPPQQAAAPPQAPPPQQN
STQTNGTAGGAGAGVGGTGAGLQHSQDSSLNQVPP
NKKPRLGPSGANSGGPVMPSDYQHSSSRLNYQSSV
QGSSQSQSTLGYSSSSQQSSQYHPSH- Isotype
- IgG
- Vial size
- 100 µl
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Submitted references
CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein α
Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
CDK8/19 Mediator kinases potentiate induction of transcription by NFκB
Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
Mediator kinase inhibition further activates super-enhancer-associated genes in AML
Cyclin C is a haploinsufficient tumour suppressor
Mediator Complex Recruits Epigenetic Regulators via Its Two Cyclin-dependent Kinase Subunits to Repress Transcription of Immune Response Genes
Wood K, Nussbaum D, Martz C, Waters A, Barrera A, Rutter J, Cerda-Smith C, Stewart A, Wu C, Cakir M, Levandowski C, Kantrowitz D, McCall S, Pierobon M, III E, Smith J, Der C, Taatjes D
2023
2023
CDK8 and CDK19 act redundantly to control the CFTR pathway in the intestinal epithelium
Prieto S, Dubra G, Camasses A, Aznar A, Begon‐Pescia C, Simboeck E, Pirot N, Gerbe F, Angevin L, Jay P, Krasinska L, Fisher D
EMBO reports 2022;24(2)
EMBO reports 2022;24(2)
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
Paulsen F, Idel C, Ribbat-Idel J, Kuppler P, Klapper L, Rades D, Bruchhage K, Wollenberg B, Brägelmann J, Perner S, Offermann A
International Journal of Molecular Sciences 2020;21(15):5508
International Journal of Molecular Sciences 2020;21(15):5508
Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay
Li J, Ji H, Porter D, Broude E, Roninson I, Chen M
Cells 2019;8(10):1208
Cells 2019;8(10):1208
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions
Steinparzer I, Sedlyarov V, Rubin J, Eislmayr K, Galbraith M, Levandowski C, Vcelkova T, Sneezum L, Wascher F, Amman F, Kleinova R, Bender H, Andrysik Z, Espinosa J, Superti-Furga G, Dowell R, Taatjes D, Kovarik P
Molecular Cell 2019;76(3):485-499.e8
Molecular Cell 2019;76(3):485-499.e8
Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat
Mediouni S, Chinthalapudi K, Ekka M, Usui I, Jablonski J, Clementz M, Mousseau G, Nowak J, Macherla V, Beverage J, Esquenazi E, Baran P, de Vera I, Kojetin D, Loret E, Nettles K, Maiti S, Izard T, Valente S, Harrich D, Prasad V
mBio 2019;10(1)
mBio 2019;10(1)
CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells
Nakamura A, Nakata D, Kakoi Y, Kunitomo M, Murai S, Ebara S, Hata A, Hara T
Oncotarget 2018;9(17):13474-13487
Oncotarget 2018;9(17):13474-13487
Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19
Park M, Shen H, Spaeth J, Tolvanen J, Failor C, Knudtson J, McLaughlin J, Halder S, Yang Q, Bulun S, Al-Hendy A, Schenken R, Aaltonen L, Boyer T
Journal of Biological Chemistry 2018;293(13):4870-4882
Journal of Biological Chemistry 2018;293(13):4870-4882
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
McDermott M, Chumanevich A, Lim C, Liang J, Chen M, Altilia S, Oliver D, Rae J, Shtutman M, Kiaris H, Győrffy B, Roninson I, Broude E
Oncotarget 2017;8(8):12558-12575
Oncotarget 2017;8(8):12558-12575
Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein α
Song Z, Xiaoli A, Zhang Q, Zhang Y, Yang E, Wang S, Chang R, Zhang Z, Yang G, Strich R, Pessin J, Yang F
Journal of Biological Chemistry 2017;292(21):8918-8932
Journal of Biological Chemistry 2017;292(21):8918-8932
Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
Nitulescu I, Meyer S, Wen Q, Crispino J, Lemieux M, Levine R, Pelish H, Shair M
EBioMedicine 2017;26
EBioMedicine 2017;26
CDK8/19 Mediator kinases potentiate induction of transcription by NFκB
Chen M, Liang J, Ji H, Yang Z, Altilia S, Hu B, Schronce A, McDermott M, Schools G, Lim C, Oliver D, Shtutman M, Lu T, Stark G, Porter D, Broude E, Roninson I
Proceedings of the National Academy of Sciences 2017;114(38):10208-10213
Proceedings of the National Academy of Sciences 2017;114(38):10208-10213
Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
Clarke P, Ortiz-Ruiz M, TePoele R, Adeniji-Popoola O, Box G, Court W, Czasch S, El Bawab S, Esdar C, Ewan K, Gowan S, De Haven Brandon A, Hewitt P, Hobbs S, Kaufmann W, Mallinger A, Raynaud F, Roe T, Rohdich F, Schiemann K, Simon S, Schneider R, Valenti M, Weigt S, Blagg J, Blaukat A, Dale T, Eccles S, Hecht S, Urbahns K, Workman P, Wienke D
eLife 2016;5
eLife 2016;5
Mediator kinase inhibition further activates super-enhancer-associated genes in AML
Pelish H, Liau B, Nitulescu I, Tangpeerachaikul A, Poss Z, Da Silva D, Caruso B, Arefolov A, Fadeyi O, Christie A, Du K, Banka D, Schneider E, Jestel A, Zou G, Si C, Ebmeier C, Bronson R, Krivtsov A, Myers A, Kohl N, Kung A, Armstrong S, Lemieux M, Taatjes D, Shair M
Nature 2015;526(7572):273-276
Nature 2015;526(7572):273-276
Cyclin C is a haploinsufficient tumour suppressor
Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour M, Liu L, Wang H, King B, Shaik S, Gutierrez A, Ordureau A, Otto T, Kreslavsky T, Baitsch L, Bury L, Meyer C, Ke N, Mulry K, Kluk M, Roy M, Kim S, Zhang X, Geng Y, Zagozdzon A, Jenkinson S, Gale R, Linch D, Zhao J, Mullighan C, Harper J, Aster J, Aifantis I, von Boehmer H, Gygi S, Wei W, Look A, Sicinski P
Nature Cell Biology 2014;16(11):1080-1091
Nature Cell Biology 2014;16(11):1080-1091
Mediator Complex Recruits Epigenetic Regulators via Its Two Cyclin-dependent Kinase Subunits to Repress Transcription of Immune Response Genes
Tsutsui T, Fukasawa R, Shinmyouzu K, Nakagawa R, Tobe K, Tanaka A, Ohkuma Y
Journal of Biological Chemistry 2013;288(29):20955-20965
Journal of Biological Chemistry 2013;288(29):20955-20965
No comments: Submit comment
No validations: Submit validation data